Genesis Growth Tech Acquisition Corp. (GGAA) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting technology companies in the consumer internet industry; it provides no current products or services beyond its SPAC structure and holds cash reserves from its initial public offering for deployment in a target acquisition. The company, founded in 2021 and headquartered in Hergiswil, Switzerland, concentrates its search efforts on opportunities in Europe, Israel, the United Arab Emirates, and the United States. In May 2024, Genesis Growth Tech Acquisition Corp. changed its name to NeuroMind AI Corp. (trading as GGAAF on OTC markets), reflecting a strategic pivot as a public company holding strategic intellectual property assets in the augmented reality/virtual reality (AR/VR) realm, aimed at developing AI-enhanced neuro-immersive experiences for diverse applications; prior to this, it pursued but mutually terminated merger agreements with Biolog-id in 2023, NextTrip in 2023, and MindMaze-related transactions involving patent purchases valued at $21 million set for 2024, while receiving Nasdaq delisting notices in 2023 for non-compliance that led to its current OTC listing.